Envarsus Xr

Active Ingredient(s): Tacrolimus
FDA Approved: * July 10, 2015
Pharm Company: * VELOXIS PHARMA INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Envarsus Xr Overview

Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After allogeneic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given. The drug can also be sold as a topical medication in the treatment of T-cell-mediated diseases such as eczema and psoriasis. For example, it is prescribed for severe refractory uveitis after a bone marrow transplant, exacerbations of minimal change disease, Kimura's disea...

Read more Envarsus Xr Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tacrolimus

Recent Envarsus Xr Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Envarsus Xr: (6 results)

Sorted by National Drug Code

• 68992-3010 Envarsus 1 mg Oral Tablet, Extended Release by Veloxis Pharmaceuticals, Inc
• 68992-3040 Envarsus 4 mg Oral Tablet, Extended Release by Veloxis Pharmaceuticals, Inc
• 68992-3075 Envarsus .75 mg Oral Tablet, Extended Release by Veloxis Pharmaceuticals, Inc
• 75929-010 Envarsus 1 mg Oral Tablet, Extended Release by Carton Service, Incorporated
• 75929-040 Envarsus 4 mg Oral Tablet, Extended Release by Carton Service, Incorporated
• 75929-075 Envarsus .75 mg Oral Tablet, Extended Release by Carton Service, Incorporated

Other drugs which contain Tacrolimus or a similar ingredient: (4 results)

• ASTAGRAF XL Tacrolimus
• PROGRAF Tacrolimus4 discussions
• PROTOPIC Tacrolimus
• TACROLIMUS 3 discussions

Related Envarsus Xr Topics: